United States · FDA National Drug Code directory
Zubsolv
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54123-957_8c67e97f-118f-4226-972a-a9031ef6f5ce
- Product NDC
- 54123-957
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- buprenorphine hydrochloride and naloxone hydrochloride
- Labeler
- Orexo US, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130704
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 5.7 mg/1
- NALOXONE HYDROCHLORIDE — 1.4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (54123-957-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 54123-957-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →